Steven P. Angus, Ph.D.
Affiliations: | 2003 | University of Cincinnati, Cincinnati, OH |
Area:
Cell Biology, Molecular BiologyGoogle:
"Steven Angus"Parents
Sign in to add mentor| Erik S. Knudsen | grad student | 2003 | University of Cincinnati | |
| (The mechanism of RB-mediated cell cycle inhibition.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chang LS, Oblinger JL, Smith AE, et al. (2021) Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. Plos One. 16: e0252048 |
| Mehta GA, Angus SP, Khella CA, et al. (2021) SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2. Npj Breast Cancer. 7: 40 |
| Pucciarelli D, Angus SP, Huang B, et al. (2020) Nf1 mutant tumors undergo transcriptome and kinome re-modeling after inhibition of either mTOR or MEK. Molecular Cancer Therapeutics |
| Park SI, Lin CP, Ren N, et al. (2019) Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma. Targeted Oncology |
| Bevill SM, Olivares-Quintero JF, Sciaky N, et al. (2019) GSK2801, a BAZ2/BRD9 bromodomain inhibitor, synergizes with BET inhibitors to induce apoptosis in triple-negative breast cancer. Molecular Cancer Research : McR |
| Smithberger E, Shelton AK, Butler MK, et al. (2019) Abstract 3019: Dynamic kinome profiling of EGFRvIII-driven murine astrocyte models of glioblastoma reveals targets for dual kinase inhibitor therapy Cancer Research. 79: 3019-3019 |
| Shih C, Blakeley J, Clapp DW, et al. (2019) Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial Cancer Research. 79 |
| Smithberger E, Shelton A, Butler M, et al. (2019) DRES-13. DUAL KINASE INHIBITION TO COMBAT EGFR-INHIBITOR RESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 21: vi74-vi74 |
| Gehlhausen JR, Hawley E, Wahle BM, et al. (2018) A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas. Human Molecular Genetics |
| Angus SP, Oblinger JL, Stuhlmiller TJ, et al. (2018) EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro-Oncology |